Case number 1:21-cv-01269
Astellas US LLC et al v. Aurobindo Pharma Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 31, 2022 | 17 | SO ORDERED (2) Docket Text: SO ORDERED, re [16] Stipulation of Dismissal, filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas Pharma US Inc., Astellas US LLC. CASE CLOSED. Signed by Judge Colm F. Connolly on 5/31/2022. (kmd) |
| May 31, 2022 | 18 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183; US RE 47,301 E; US 8,524,883. (Attachments: # (1) Stipulation and Order of Dismissal)(kmd) |
| May 31, 2022 | 18 | Stipulation and Order of Dismissal (2) |
| May 27, 2022 | 16 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal as to Defendant Aurobindo Pharma Limited by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc., Astellas Pharma US Inc.. (Oakes, Robert) |
| Dec 6, 2021 | 15 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Kenneth L. Dorsney, Cortlan S. Hitch and Morris James LLP for Aurobindo by Aurobindo Pharma Limited (Dorsney, Kenneth) |
| Dec 3, 2021 | 14 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,106,183 B2, 8,524,883 B2, and RE 47,301 E and Supporting Exhibit A-C filed by Aurobindo Pharma Limited.(Myer, R.) |
| Nov 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, filed by Aurobindo Pharma Limited. Ordered by Judge Colm F. Connolly on 11/29/2021. (kmd) |
| Nov 29, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Timothy H. Kratz for Aurobindo Pharma Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Nov 26, 2021 | 13 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz - filed by Aurobindo Pharma Limited. (Myer, R.) |
| Nov 18, 2021 | 12 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Limited (Myer, R.) |
| Sep 21, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:21-cv-00671-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 21-671-CFC ONLY. (nmf) |
| Sep 21, 2021 | 9 | Answer to Complaint (13) Docket Text: ANSWER to [1] Complaint, by Aurobindo Pharma Limited.(Dorsney, Kenneth) |
| Sep 21, 2021 | 10 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aurobindo Pharma Limited. (Dorsney, Kenneth) |
| Sep 21, 2021 | 11 | SO ORDERED (3) Docket Text: SO ORDERED, re (8 in 1:21-cv-01269-CFC) STIPULATION and Order to Consolidate Action. C.A. 21-671-CFC and C.A. 21-1269-CFC are consolidated for all purposes. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 21-671-CFC. See order for further details. Signed by Judge Colm F. Connolly on 9/21/2021. Associated Cases: 1:21-cv-00671-CFC, 1:21-cv-01269-CFC(nmf) |
| Sep 17, 2021 | 8 | Stipulation (3) Docket Text: STIPULATION and Proposed Order to Consolidate Action by Astellas Pharma US Inc., Astellas US LLC, Gilead Sciences, Inc.. (Del Dotto, Kelly) |
| Sep 9, 2021 | 6 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;US RE 47,301 E ;US 8,524,883. (apk) |
| Sep 9, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Astellas US LLC, Astellas Pharma US Inc., Gilead Sciences, Inc.: For Aurobindo Pharma Limited waiver sent on 9/8/2021, answer due 11/8/2021. (Del Dotto, Kelly) |
| Sep 8, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Sep 3, 2021 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (apk) |
| Sep 3, 2021 | 1 | Main Document (12) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3692322.) - filed by Astellas US LLC, Astellas Pharma US Inc., Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Civil Cover Sheet)(apk) |
| Sep 3, 2021 | 1 | Exhibit A (22) |
| Sep 3, 2021 | 1 | Exhibit B (22) |
| Sep 3, 2021 | 1 | Exhibit C (20) |
| Sep 3, 2021 | 1 | Exhibit D (18) |
| Sep 3, 2021 | 1 | Civil Cover Sheet (1) |
| Sep 3, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Sep 3, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/10/2021. Date of Expiration of Patent: 02/2/2027.Thirty Month Stay Deadline: 2/9/2024. (apk) |
| Sep 3, 2021 | 4 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US Inc., Astellas US LLC filed by Astellas Pharma US Inc., Astellas US LLC. (apk) |
| Sep 3, 2021 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc. (apk) |
| Sep 3, 2021 | 1 | Complaint* (1) |
